Dupilumab SAR231893 (REGN668) clinical trials

Observational Study of Patients Receiving Dupixent® for Atopic Dermatitis (AD)

This study looks at how Dupixent (a medicine for eczema) works for people with eczema in their everyday lives. Researchers want to understand who uses it, how they use it, and how effective and safe it is over time.